Status:
NOT_YET_RECRUITING
The Diagnostic Utility of T Immunoglobulin G and T Immunoglobulin M Biomarkers in Patients With Systemic Lupus Erythematosus Disease : Associations With Disease Activity and Damage
Lead Sponsor:
Assiut University
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The SLE is heterogeneous multisystem autoimmune disease with complex pathogenesis involves multiple cellular components of the innate and adaptive immune systems, presence of autoantibodies and immune...
Eligibility Criteria
Inclusion
- : Adult SLE Patients ( \>18 years ) who are fulfilling the 2019 ACR\\EULAR classification criteria of systemic lupus erythematosus
Exclusion
- SLE patients \<18 years old
- Patients with other autoimmune diseases (systemic sclerosis , sjogren syndrome, rheumatoid arthritis dermatomyositis, mixed connective tissue disease).
- Pregnant and lactating women .
- \-
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07136337
Start Date
September 1 2025
End Date
January 1 2028
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospital
Asyut, Asyut Governorate, Egypt, 1111